# Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and … – Nature > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/developmental-variation-in-basal-ganglia-tissue-iron-neurocognitive-functioning-and-nature/ > **Published:** 2026-06-12T07:52:30-04:00 | **Last Modified / Clinically Audited:** 2026-09-08T20:23:45-04:00 > **Clinical Summary:** New research links adolescent cannabis use to basal ganglia iron changes. Clinical implications for teen brain development and neurocognitive risk. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchPediatricsMental HealthSafetyTHCAnxiety Clinical Summary # Clinical Summary This study examines the relationship between [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) and structural changes in the basal ganglia, specifically focusing on tissue iron accumulation and its association with neurocognitive outcomes. The research suggests that cannabis exposure during the critical developmental period of adolescence may alter iron homeostasis in brain regions crucial for motor control, motivation, and cognitive processing, potentially leading to measurable deficits in attention, processing speed, and executive function. These findings are particularly concerning given the vulnerable neurodevelopmental stage of adolescence, when the brain is still establishing neural circuits and optimizing neural efficiency. For clinicians, this evidence strengthens the rationale for counseling adolescent patients and their families about the risks of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during this critical window, as early-onset use may have long-term consequences on cognitive development and academic or occupational functioning. The mechanistic link between cannabis exposure and basal ganglia iron dysregulation provides a biological basis for understanding why some adolescent users experience persistent cognitive changes even after cessation. Clinicians should incorporate discussion of these developmental neurotoxic risks into their screening and counseling for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in young patients, particularly those with baseline cognitive vulnerabilities or academic concerns. Dr. Caplan’s Take “The iron accumulation patterns we’re seeing in [adolescent cannabis](https://cedclinic.com/cannabis-use-disorder-psychiatric-risk/) users suggest we’re not just dealing with functional impairment but potentially irreversible neurobiological changes during a critical developmental window, which means the clinical conversation with young patients needs to shift from ‘cannabis is safer than alcohol’ to ‘your brain is still building itself until age 25, and we have emerging evidence this matters.’” Clinical Perspective 💭 This emerging research examining associations between [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) and basal ganglia iron accumulation adds to growing evidence that cannabis exposure during critical developmental periods may have measurable neurobiological effects, though the clinical significance of these findings remains unclear. The basal ganglia’s role in motor control, reward processing, and [cognitive function](https://cedclinic.com/reverse-cholesterol-transport-function-cannabis-users/) makes this region particularly relevant to understanding potential long-term consequences of early [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), yet the cross-sectional or observational nature of such studies cannot establish causation and may be confounded by genetic predisposition, concurrent substance use, or socioeconomic factors that influence both cannabis initiation and neurodevelopmental outcomes. Healthcare providers should recognize that while adolescent [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) has reduced legal barriers to use in many jurisdictions, the developing brain’s vulnerability to cannabinoids remains a legitimate clinical concern that warrants discussion during preventive care visits. Until mechanistic studies clarify whether observed neurobiological changes translate to functional impair 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Developmental%20variation%20in%20basal%20ganglia%20tissue%20iron%2C%20neurocognitive%20functioning%2C%20and%20...%20-%20Nature%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D58922)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D58922)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Developmental%20variation%20in%20basal%20ganglia%20tissue%20iron%2C%20neurocognitive%20functioning%2C%20and%20...%20-%20Nature%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D58922)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.nature.com/articles/s41467-026-73611-1](https://www.nature.com/articles/s41467-026-73611-1) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).